Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Neurovascular Catheters Market, by Type
1.4.2 LAMEA Neurovascular Catheters Market, by End Use
1.4.3 LAMEA Neurovascular Catheters Market, by Application
1.4.4 LAMEA Neurovascular Catheters Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.2.5 Trials and Approvals
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
Chapter 4. LAMEA Neurovascular Catheters Market by Type
4.1 LAMEA Embolization Catheters Market by Country
4.2 LAMEA Access Catheters Market by Country
4.3 LAMEA Balloon Catheters Market by Country
4.4 LAMEA Microcatheters Market by Country
4.5 LAMEA Others Market by Country
Chapter 5. LAMEA Neurovascular Catheters Market by End-use
5.1 LAMEA Hospitals Market by Country
5.2 LAMEA Clinics Market by Country
5.3 LAMEA Ambulatory Surgical Centers Market by Country
5.4 LAMEA Diagnostic Centers Market by Country
Chapter 6. LAMEA Neurovascular Catheters Market by Application
6.1 LAMEA Brain Aneurysm Market by Country
6.2 LAMEA Embolic Stroke Market by Country
6.3 LAMEA Arteriovenous Malformations Market by Country
6.4 LAMEA Hydrolysate Market by Country
Chapter 7. LAMEA Neurovascular Catheters Market by Country
7.1 Brazil Neurovascular Catheters Market
7.1.1 Brazil Neurovascular Catheters Market by Type
7.1.2 Brazil Neurovascular Catheters Market by End-use
7.1.3 Brazil Neurovascular Catheters Market by Application
7.2 Argentina Neurovascular Catheters Market
7.2.1 Argentina Neurovascular Catheters Market by Type
7.2.2 Argentina Neurovascular Catheters Market by End-use
7.2.3 Argentina Neurovascular Catheters Market by Application
7.3 UAE Neurovascular Catheters Market
7.3.1 UAE Neurovascular Catheters Market by Type
7.3.2 UAE Neurovascular Catheters Market by End-use
7.3.3 UAE Neurovascular Catheters Market by Application
7.4 Saudi Arabia Neurovascular Catheters Market
7.4.1 Saudi Arabia Neurovascular Catheters Market by Type
7.4.2 Saudi Arabia Neurovascular Catheters Market by End-use
7.4.3 Saudi Arabia Neurovascular Catheters Market by Application
7.5 South Africa Neurovascular Catheters Market
7.5.1 South Africa Neurovascular Catheters Market by Type
7.5.2 South Africa Neurovascular Catheters Market by End-use
7.5.3 South Africa Neurovascular Catheters Market by Application
7.6 Nigeria Neurovascular Catheters Market
7.6.1 Nigeria Neurovascular Catheters Market by Type
7.6.2 Nigeria Neurovascular Catheters Market by End-use
7.6.3 Nigeria Neurovascular Catheters Market by Application
7.7 Rest of LAMEA Neurovascular Catheters Market
7.7.1 Rest of LAMEA Neurovascular Catheters Market by Type
7.7.2 Rest of LAMEA Neurovascular Catheters Market by End-use
7.7.3 Rest of LAMEA Neurovascular Catheters Market by Application
Chapter 8. Company Profiles
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Approvals and Trials:
8.1.6 SWOT Analysis
8.2 Johnson & Johnson (Johnson & Johnson Services, Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental &Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.6 SWOT Analysis
8.3 Penumbra, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.3.5.3 Approvals and Trials:
8.4 Integer Holdings Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Acquisition and Mergers:
8.4.5.2 Geographical Expansions:
8.5 Terumo Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Regional Analysis
8.5.5 Recent strategies and developments:
8.5.5.1 Product Launches and Product Expansions:
8.6 Stryker Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Approvals and Trials:
8.6.5.2 Geographical Expansions:
8.7 Integra LifeSciences Holdings Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.8 Acandis GmbH
8.8.1 Company Overview
8.9 Spiegelberg GmbH & Co. KG.
8.9.1 Company Overview
8.10. RAUMEDIC AG (REHAU Industries SE & Co. KG)
8.10.1 Company Overview
Unique Offerings 